Evaluation of fibroblast growth factor 23 as a marker of severity in stable chronic obstructive pulmonary disease. Monaldi Arch Chest Dis [Internet]. 2025 Jun. 5 [cited 2026 Oct. 10];96(3). Available from: https://www.monaldi-archives.org/macd/article/view/3271